Chambers Review
Provided by Chambers
Email address
[email protected]Contact number
+1 650 843 5000Provided by Chambers
Cooley advised Beta Bionics on its $234.6 million IPO of 13,800,000 shares of common stock at a public offering price of $17.00 per share.
Provided by Chambers
Cooley has immensely commercially-minded attorneys who are really good at helping us understand all of the issues whilst focusing on the ones that matter, which helps us make better business decisions.
Cooley has significant deal expertise and is extremely thoughtful in providing advice based on what the team has observed in the market and recent precedents.
The firm actually gets to know us and our business, which makes its advice so much more practical and actionable.
When it comes to capital markets transactions for high-growth companies, you just are not going to find a better partner than Cooley.
The Cooley team has incredible practicality, as well as deep expertise in the spaces where I need them to be experts.
Cooley has immensely commercially-minded attorneys who are really good at helping us understand all of the issues whilst focusing on the ones that matter, which helps us make better business decisions.
Cooley has significant deal expertise and is extremely thoughtful in providing advice based on what the team has observed in the market and recent precedents.
The firm actually gets to know us and our business, which makes its advice so much more practical and actionable.
When it comes to capital markets transactions for high-growth companies, you just are not going to find a better partner than Cooley.
The Cooley team has incredible practicality, as well as deep expertise in the spaces where I need them to be experts.
Provided by Chambers

Eric Jensen is a recommended choice of counsel for issuers and underwriters on a broad range of capital markets transactions, from IPOs to debt mandates.

Charlie Kim is co-chair of Cooley’s global capital markets practice group. He is best known for his expertise in the life sciences and technology sectors, where he frequently advises underwriters and issuers on IPOs and debt offerings.
Charlie is the standout attorney at the firm.

David Peinsipp is held in high esteem for his standout experience handling high-value IPOs and major debt offerings on behalf of technology and life sciences companies.
David is adept at weighing the risks against the benefits.

Christina Roupas is known for representing tech clients through various equity transactions including IPOs and common stock offerings.
Christina is the best. She will find a creative solution for pretty much any situation.
Christina is terrific, on top of it and adept at navigating complexities with different types of clients.
Christina has great experience and enjoys assisting even in the most challenging areas.
She is extremely responsive and highly technically competent.

Divakar is a fantastic partner and leader.
Divakar is practical, efficient and thoughtful.
He has consistently taken a proactive approach to supporting the company, helping the board to think through relevant considerations and, most importantly, take a solution-oriented approach.

Jon Avina is sought after by leading tech companies, and their underwriters, for his knowledge of debt and equity transactions.
Jon is incredible on corporate matters.

Courtney Tygesson has experience guiding tech firms through the variety of equity transactions including IPOs and common stock issuances.
Courtney is a fabulous biotech securities lawyer.
Courtney is always willing to assist and extremely knowledgeable while remaining approachable.
Courtney is phenomenal, very sharp, business-minded and gives practical advice.
Courtney is exceptional.
Courtney is a phenomenal practitioner.

Denny Won regularly acts on significant capital markets transactions for a number of leading investment banks.
Denny is technically strong.
Denny does deep diligence and is highly sophisticated to work with.
Denny is able to focus on the ultimate transactional goal while still representing his client's interests.
Eric has deep technical knowledge of securities law and advises based on a practical approach tailored to our business risk.
Eric is fantastic, he is just great to work with.

Gian-Michele a Marca attracts widespread praise for his debt capital markets practice, with notable expertise in convertible debt transactions. He routinely offers counsel to clients within the technology and pharmaceutical sectors.
He is a leading practitioner in the convertible financing space.

John-Paul Motley is praised for his securities law practice, which encompasses the representation of issuers and underwriters on the comprehensive range of debt and equity transactions.

Kristin VanderPas has a strong client base of leading investment banks and companies in the tech and life sciences sectors.

Milson Yu frequently acts on behalf of companies and investment banks in a variety of capital market transactions.
Milson does exceptional work for us. He knows our business very well, always knows the answer and makes helpful recommendations.

Richard Segal acts for both underwriters and issuers in high-value capital markets transactions. He offers notable skill in IPOs.
He is responsive, attentive and great to work with.
I cannot say enough about his skill in navigating highly complex issues while being practical in his approach. He is excellent.
Richard's vast experience allows him to push deals forward efficiently and effectively.
Richard is highly responsive and can be trusted in very complex and cross-border situations.












